70 related articles for article (PubMed ID: 3015556)
1. The Melanocortin and Endorphin Neuropeptides in Patients with Restless Legs Syndrome.
Koo BB; Abdelfattah A; Eysa A; Lu L
Ann Neurol; 2024 Apr; 95(4):688-699. PubMed ID: 38308537
[TBL] [Abstract][Full Text] [Related]
2. Low resting metabolic rate and increased hunger due to β-MSH and β-endorphin deletion in a canine model.
Dittmann MT; Lakatos G; Wainwright JF; Mokrosinski J; Cross E; Farooqi IS; Wallis NJ; Halsey LG; Wilson R; O'Rahilly S; Yeo GSH; Raffan E
Sci Adv; 2024 Mar; 10(10):eadj3823. PubMed ID: 38446876
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of Cushing's disease: Overview and recent findings.
Praw SS; Heaney AP
Int J Gen Med; 2009 Dec; 2():209-17. PubMed ID: 20360906
[TBL] [Abstract][Full Text] [Related]
4. Mislocalization of protein kinase A drives pathology in Cushing's syndrome.
Omar MH; Byrne DP; Jones KN; Lakey TM; Collins KB; Lee KS; Daly LA; Forbush KA; Lau HT; Golkowski M; McKnight GS; Breault DT; Lefrançois-Martinez AM; Martinez A; Eyers CE; Baird GS; Ong SE; Smith FD; Eyers PA; Scott JD
Cell Rep; 2022 Jul; 40(2):111073. PubMed ID: 35830806
[TBL] [Abstract][Full Text] [Related]
5. Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases.
Tardo AM; Reusch CE; Galac S; Fornetti S; Tirolo A; Golinelli S; Shehdula D; Fracassi F
J Feline Med Surg; 2021 Feb; 23(2):67-73. PubMed ID: 32478637
[TBL] [Abstract][Full Text] [Related]
6. Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Al Musaimi O
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540684
[TBL] [Abstract][Full Text] [Related]
7. Cushing's treatment for horses.
Vet Rec; 2024 Mar; 194(6):219. PubMed ID: 38488580
[No Abstract] [Full Text] [Related]
8. Diagnosis of canine spontaneous hypoadrenocorticism.
Guzmán Ramos PJ; Bennaim M; Shiel RE; Mooney CT
Canine Med Genet; 2022 May; 9(1):6. PubMed ID: 35505424
[TBL] [Abstract][Full Text] [Related]
9. Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.
Lloyd RV; D'Amato CJ; Thiny MT; Jin L; Hicks SP; Chandler WF
Endocr Pathol; 1993 Jun; 4(2):86-94. PubMed ID: 32138413
[TBL] [Abstract][Full Text] [Related]
10. TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism.
Pijnacker T; Knies M; Galac S; Sanders K; Mol JA; Kooistra HS
Vet Q; 2018 Dec; 38(1):72-78. PubMed ID: 30362899
[TBL] [Abstract][Full Text] [Related]
11. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.
Langlois DK; Fritz MC; Schall WD; Bari Olivier N; Smedley RC; Pearson PG; Bailie MB; Hunt SW
BMC Endocr Disord; 2018 May; 18(1):24. PubMed ID: 29720169
[TBL] [Abstract][Full Text] [Related]
12. Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.
Croughs RJ; Thijssen JH; Mol JA
J Endocrinol Invest; 1991 Mar; 14(3):197-200. PubMed ID: 1649212
[TBL] [Abstract][Full Text] [Related]
13. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
14. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
Orth DN; Peterson ME; Drucker WD
Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
[TBL] [Abstract][Full Text] [Related]
16. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713
[TBL] [Abstract][Full Text] [Related]
17. [Recent data on the group of melanotropic and lipotropic pituitary hormones (MSH-LPH) and on the brain morphinomimetic peptides (endorphins)].
Bertagna X; Girard F
Ann Endocrinol (Paris); 1978; 39(3):201-13. PubMed ID: 214012
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of the pituitary.
Doniach I
Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
